Balaji Amines Limited has convened its 38th Annual General Meeting (AGM) on Friday, July 10, 2026, at 12:00 Noon IST through Video Conferencing (VC) and Other Audio Visual Means (OAVM). The meeting will transact ordinary and special business including adoption of audited financial statements, declaration of dividend, and re-appointment of a director. The AGM notice and Annual Report for FY26 have been dispatched electronically to members registered with the company, depositories, or the Registrar and Transfer Agent, in compliance with Regulation 30 and 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dividend and Record Date

The Board of Directors recommended a final dividend of ₹11 per equity share for FY26, representing 550% of the face value of ₹2 each, at its meeting held on May 13, 2026. The dividend, subject to deduction of tax at source, will be paid within 30 days from the conclusion of the AGM, subject to shareholder approval. The company has fixed Friday, July 3, 2026, as the record date to determine shareholder eligibility, in compliance with Regulation 42 of the SEBI (LODR) Regulations, 2015. The share transfer books and Register of Members will remain closed from Saturday, July 4, 2026, to Friday, July 10, 2026 (both days inclusive). This marks the seventh consecutive year the Board has recommended a dividend of ₹11 per share, and the total cash outflow on account of dividend would be ₹3,564.11 Lakhs.

FY26 Financial Performance

Balaji Amines delivered a strong financial performance in FY26. The following table summarises key consolidated and standalone financial highlights:

The fourth quarter was the company's strongest in years, delivering consolidated revenue of ₹403 crore, EBITDA of ₹102 crore at a 25% margin, and PAT of ₹65 crore, up 62% year-on-year. The standalone entity remains entirely debt-free, with all expansion projects funded from internal cash generation.

Consolidated Key Financial Ratios

The table below presents key consolidated financial ratios for FY26 versus FY25:

Consolidated Segment-wise Sales Performance

Operational Milestones and R&D Pipeline

FY26 marked several key commissioning milestones for Balaji Amines. The company's methylamines plant (88,000 TPA), the largest in India built on indigenous technology, completed its first full year of operations. The MIPA plant was commissioned in Q1 FY26, and Electronic Grade DMC was commissioned in May 2025, making Balaji Amines the sole domestic manufacturer of this critical element for EV batteries. A 6 MW solar plant commenced generation in April 2025, with approximately 30% of manufacturing energy now sourced from solar. The company's R&D pipeline includes several projects at various stages:

Subsidiary and Credit Rating

Balaji Speciality Chemicals Limited (BSCL), the company's only subsidiary in which it holds 55% equity, reported turnover of ₹15,241.43 Lakhs, PBT of ₹580.64 Lakhs, and PAT of ₹434.87 Lakhs for the period ended March 31, 2026. The greenfield expansion project at MIDC, Chincholi, Solapur, involves an investment of ₹750 crore as a mega project in a phased manner to manufacture high-technology products including Hydrogen Cyanide, Sodium Cyanide, and EDTA. The company's credit rating was affirmed during the year as "IND AA/Negative/IND A1+" by India Ratings and Research Private Limited.

AGM Agenda and E-Voting

The 38th AGM will transact ordinary business including adoption of audited financial statements, declaration of the ₹11 per share dividend, and re-appointment of Mr. Ande Srinivas Reddy (Whole-time Director & CFO) who retires by rotation. Special business includes ratification of remuneration of ₹75,000/- (plus GST and out-of-pocket expenses) to Mr. Narayan D. Dontul as Cost Auditor for FY 2026-27. Remote e-voting will be facilitated by NSDL from Tuesday, July 7, 2026, at 9:00 A.M. to Thursday, July 9, 2026, at 5:00 P.M. The record date for e-voting eligibility is Friday, July 3, 2026.

Balaji Amines Co-Chairman Anup Pratap Reddy has outlined a positive growth outlook for the company, projecting volume growth of 10-15% for FY27 alongside an EBITDA margin in the range of 22-23%. The guidance reflects the company's confidence in its operational trajectory as key production capacities are scaled up across multiple product segments.

Growth Outlook and Margin Guidance

The following table summarizes the key projections shared by Co-Chairman Anup Pratap Reddy:

Medium-Term Expansion Driven by Key Product Lines

Beyond FY27, Balaji Amines is targeting a more accelerated volume growth of 20-30% over the medium term. This higher growth trajectory is expected to be supported by increased production across four key product lines:

• DME (Dimethyl Ether)
• NMM (N-Methyl Morpholine)
• ACN (Acetonitrile)
• BSCL (Bis(2-chloroethyl) amine or related specialty chemical, as referenced in source)

The ramp-up in production capacity across these segments is central to the company's medium-term volume growth strategy, as highlighted by the Co-Chairman.

Summary

Balaji Amines has articulated a clear near-term and medium-term growth roadmap. For FY27, the company targets volume growth of 10-15% with EBITDA margins of 22-23%, while its medium-term ambition of 20-30% volume growth is anchored in expanding production of DME, NMM, ACN, and BSCL.